Warburg Pincus to buy Lifecore Biomedical INC for sure

Warburg Pincus received an agreement from Lifecore Biomedical INC to buy it through a tender offer, followed by a merger, for a price of $17.00 per share in cash with total transaction value of $239 million.

Lifecore Biomedical said that the $17.00 per share price represents a premium of approximately 30% over the volume weighted average price of Lifecore Biomedical's shares for the last 30 trading days.

Warburg Pincus is a private equity firm with offices in the United States, Europe and Asia. It has been a leading private equity investor since 1971. The firm currently has approximately $14 billion under management, and invests in a range of industries including information and communication technology, financial services, healthcare, leveraged buyouts and special situations, media and business services, energy and real estate.

Warburg Pincus also has a long history as a leading investor in the information and communication technology sectors, including investments in Avaya, BEA Systems, Bharti Tele-Ventures, Cassatt, Harbour Networks, NeuStar, Telcordia and VERITAS Software. The firm is an experienced partner to entrepreneurs seeking to create and build durable companies with sustainable value. Warburg Pincus has an active portfolio of more than 115 companies spanning the entire spectrum of scale and maturity.

Subscribe to Pravda.Ru Telegram channel, Facebook, RSS!

Author`s name Editorial Team